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Introduction
Progressive Supranuclear Palsy (PSP) is an uncommon neurodegenerative disease associated with postural instability, falling, and memory loss. Because of clinical similarities,
it is often classified as atypical Parkinson's disease. PSP may present abruptly with a relatively rapid decline, leading to death in a few years. Different therapeutic approaches
have been suggested for PSP, but their efficacy is unclear. To our knowledge, there has been no systematic review of PSP treatment.

Objective
To determine the effectiveness PSP treatments.
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Literature sources: PubMed, SCOPUS and
"gray" literature.
Initial inclusion criteria:
English.
Published between January 1, 1994 to January
2015.
Published data on a treatment intervention for
PSP patients.
Exclusion criteria:
No comparison group.
No clear, defined interventions.
Outcome(s) that were not objective (we allowed
opinion/observations recorded by the patient or
a family member).
Outcome assessors not blinded to the
intervention.
The control population needed to have an
intervention similar to the experimental
intervention (an attention sham).

Results
The initial search obtained 617 publications. Of these, 28 met
our inclusion criteria. These were grouped by therapy:
2 dealt with an ophthalmic interventions

While a number of articles had suggestive findings,
we found only 9 acceptable articles. They either
showed the subject therapy was not efficacious, or
the effects were not clearly beneficial to the patient.
A meta-analysis was not possible.

3 with a PT/rehabilitation intervention

Authors’ conclusions

4 with some intracranial procedures

17 dealt with medications

2 dealt with 2 or more types of intervention.

No therapy has been established as efficacious for
PSP. Studies of one medication, Co-Q 10, have been
encouraging in phase 2 study, and a phase 3 study is
currently active. An approach using physical therapy
(balance training) and eye movement rehabilitation
found some benefit in gait and general mobility, but
there was no adequate control and the overall benefit
to patients (falls, quality of life, hospitalization, etc.)
was not evaluated.

